YU58299A - Efikasna enantioselektivna adiciona reakcija uz upotrebu organskog cink reagensa - Google Patents

Efikasna enantioselektivna adiciona reakcija uz upotrebu organskog cink reagensa

Info

Publication number
YU58299A
YU58299A YU58299A YU58299A YU58299A YU 58299 A YU58299 A YU 58299A YU 58299 A YU58299 A YU 58299A YU 58299 A YU58299 A YU 58299A YU 58299 A YU58299 A YU 58299A
Authority
YU
Yugoslavia
Prior art keywords
addition reaction
organozinc reagent
enantioselective addition
efficient enantioselective
chloro
Prior art date
Application number
YU58299A
Other languages
English (en)
Inventor
Cheng Yi Chen
Richard D. Tillyer
Lushi Tan
Original Assignee
Merck & Co.Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9711599A external-priority patent/GB9711599D0/en
Priority claimed from GB9727129A external-priority patent/GB9727129D0/en
Application filed by Merck & Co.Inc. filed Critical Merck & Co.Inc.
Publication of YU58299A publication Critical patent/YU58299A/sh
Publication of RS49860B publication Critical patent/RS49860B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/68—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Efikasan postupak za dobijanje ključnog intermedijara u sintezi (-)-6-hlor-4-ciklopropiletinil-4-trifluorometil-1,4-dihidro-2H-3,1-1benzoksazin-2-ona, inhibitora reverzne transkriptaze se postiže upotrebljavajući hiralnu adicionu reakciju na 4-hlor-2-trifluorometilketoanilin sa organskim kompleksom cinka, pri čemu se dobija željeni alkohol. Ovaj postupak ima široku primenu u hiralnoj adiciji na bilo koji prohiralni keton.[An efficient method for the preparation of key intermediate, in the synthesis of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4- dihydro-2H-3,1-benzoxazin-2-one, a reverse transcriptase inhibitor is achieved using a chiral addition reaction to the 4-chloro-2- trifluoromethylke-toaniline with an organozinc complex to give the desired alcohol. This instant method has broad applicability in the chiral addition to any prochiral ketone.
YUP-582/99A 1997-05-16 1998-05-12 Efikasna enantioselektivna adiciona reakcija uz upotrebu organskog cink reagensa RS49860B (sr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4671397P 1997-05-16 1997-05-16
GB9711599A GB9711599D0 (en) 1997-06-05 1997-06-05 Efficient enatioselective addition reation using an organozinc reagent
US5788497P 1997-09-03 1997-09-03
GB9727129A GB9727129D0 (en) 1997-12-22 1997-12-22 Efficient enantioselective addition reaction using an organozinc reagent
US8352598P 1998-04-29 1998-04-29

Publications (2)

Publication Number Publication Date
YU58299A true YU58299A (sh) 2001-12-26
RS49860B RS49860B (sr) 2008-08-07

Family

ID=27547294

Country Status (26)

Country Link
US (1) US6015926A (sh)
EP (1) EP0981520B1 (sh)
JP (1) JP3273615B2 (sh)
KR (1) KR100566683B1 (sh)
CN (1) CN1106389C (sh)
AR (1) AR011731A1 (sh)
AT (1) ATE270666T1 (sh)
AU (1) AU739250B2 (sh)
BR (1) BR9809628A (sh)
CA (1) CA2289206C (sh)
CZ (1) CZ297968B6 (sh)
DE (1) DE69824958T2 (sh)
DK (1) DK0981520T3 (sh)
EA (1) EA002192B1 (sh)
ES (1) ES2224396T3 (sh)
HR (1) HRP980266B1 (sh)
HU (1) HU226881B1 (sh)
NZ (1) NZ500526A (sh)
PL (1) PL193448B1 (sh)
PT (1) PT981520E (sh)
RS (1) RS49860B (sh)
SI (1) SI0981520T1 (sh)
SK (1) SK285446B6 (sh)
TW (1) TWI221833B (sh)
UA (1) UA59396C2 (sh)
WO (1) WO1998051676A1 (sh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6201158B1 (en) * 1998-06-22 2001-03-13 Merck & Co., Inc. Process for making intermediate aldehydes
EP1756072A2 (en) 2004-04-27 2007-02-28 Wyeth Purification of progesterone receptor modulators
US20090163601A1 (en) * 2007-12-21 2009-06-25 The Regents Of The University Of California (r)-2-methyl-(2,5-dimethylphenyl)propanol and (s)-(2-methyl-2,5-dimethylphenyl)propanol
ZA200806473B (en) * 2008-01-31 2009-04-29 Aptuit Laurus Pvt Ltd An efficient process to induce enantioselectivity in procarbonyl compounds
US9073817B2 (en) 2008-01-31 2015-07-07 Laurus Labs Private Limited Efficient process to induce enantioselectivity in procarbonyl compounds
US20110071287A1 (en) * 2008-05-01 2011-03-24 Ranbaxy Laboratories Limited Process for the preparation of efavirenz
EP2313379B1 (en) 2008-05-30 2015-03-11 Emcure Pharmaceuticals Limited Process for the preparation of efavirenz
KR100878436B1 (ko) * 2008-08-18 2009-01-13 주식회사 지씨에이치앤피 금은화 추출물을 포함하는 소화성 궤양 치료 또는 예방용 약학조성물
US20110172419A1 (en) * 2009-04-09 2011-07-14 Aleksander Warm Process for the synthesis of cyclic carbamates
WO2010115638A2 (en) * 2009-04-09 2010-10-14 Lonza Ltd. Autocatalytic process for the synthesis of chiral propargylic alcohols
WO2010115641A1 (en) * 2009-04-09 2010-10-14 Lonza Ltd Process for the synthesis of chiral cyclic carbamates
WO2010115639A1 (en) * 2009-04-09 2010-10-14 Lonza Ltd Process for the synthesis of a propargylic alcohol
EP2448917A2 (de) 2009-07-03 2012-05-09 Archimica GmbH Verfahren zur enantioselektiven addition von organometallischen kohlenstoffnukleophilen an trifluormethylketone und verwendung des verfahrens in der synthese von hiv reverse transcriptase inhibitoren
US8080655B2 (en) * 2009-07-20 2011-12-20 Apotex Pharmachem Inc. Methods of making efavirenz and intermediates thereof
EP2447255A1 (en) 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of cyclic carbamates
EP2447247A1 (en) * 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of chiral propargylic alcohols
EP2441759A1 (en) 2010-10-14 2012-04-18 Lonza Ltd. Process for the synthesis of cyclic carbamates
WO2012079235A1 (en) * 2010-12-16 2012-06-21 Lonza Ltd Process for preparing efavirenz
CN103254087B (zh) * 2013-06-07 2015-03-18 郑州大学 依非韦伦中间体的制备方法
CN105330554B (zh) * 2015-02-15 2017-07-11 上海迪赛诺药业股份有限公司 手性环丙基乙炔基叔醇类化合物的合成方法
DE202015104551U1 (de) 2015-08-27 2015-12-03 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Reaktoren für die Herstellung von Efavirenz sowie Zwischenprodukte
NL2018412B1 (en) * 2017-02-23 2018-09-17 Univ Nelson Mandela Metropolitan Method for the manufacture of efavirenz
CN106946718A (zh) * 2017-04-27 2017-07-14 武汉工程大学 一种合成依非韦伦中间体的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519021A (en) * 1992-08-07 1996-05-21 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5663467A (en) * 1995-01-23 1997-09-02 Merck & Co., Inc. Synthesis of cyclopropylacetylene
US5633405A (en) * 1995-05-25 1997-05-27 Merck & Co., Inc. Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one
JP2000507970A (ja) * 1997-01-10 2000-06-27 メルク エンド カンパニー インコーポレーテッド キラルメディエータの効率的な合成
EP0975609B1 (en) * 1997-02-05 2010-10-27 Merck Sharp & Dohme Corp. Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
TW480253B (en) * 1997-02-12 2002-03-21 Merck & Co Inc Efficient synthesis of a 1,4-dihydro-2H-3,1-benzoxazin-2-one

Also Published As

Publication number Publication date
PL336717A1 (en) 2000-07-03
HU226881B1 (en) 2010-01-28
AU7470798A (en) 1998-12-08
RS49860B (sr) 2008-08-07
JP3273615B2 (ja) 2002-04-08
CZ404699A3 (cs) 2000-07-12
NZ500526A (en) 2001-07-27
DE69824958T2 (de) 2005-07-14
JP2000513746A (ja) 2000-10-17
CN1255919A (zh) 2000-06-07
HUP0003404A2 (hu) 2000-12-28
ATE270666T1 (de) 2004-07-15
SI0981520T1 (en) 2004-10-31
CA2289206A1 (en) 1998-11-19
AR011731A1 (es) 2000-08-30
HRP980266B1 (en) 2002-10-31
KR20010012650A (ko) 2001-02-26
UA59396C2 (uk) 2003-09-15
KR100566683B1 (ko) 2006-04-03
DK0981520T3 (da) 2004-11-01
SK156299A3 (en) 2000-07-11
EA199901040A1 (ru) 2000-04-24
ES2224396T3 (es) 2005-03-01
AU739250B2 (en) 2001-10-04
TWI221833B (en) 2004-10-11
CA2289206C (en) 2008-02-05
SK285446B6 (sk) 2007-01-04
DE69824958D1 (de) 2004-08-12
HUP0003404A3 (en) 2003-06-30
BR9809628A (pt) 2000-07-04
US6015926A (en) 2000-01-18
WO1998051676A1 (en) 1998-11-19
PT981520E (pt) 2004-10-29
EP0981520A1 (en) 2000-03-01
EA002192B1 (ru) 2002-02-28
EP0981520B1 (en) 2004-07-07
HRP980266A2 (en) 1999-02-28
CZ297968B6 (cs) 2007-05-09
PL193448B1 (pl) 2007-02-28
CN1106389C (zh) 2003-04-23

Similar Documents

Publication Publication Date Title
HRP980266B1 (en) Efficient enantioselective addition reaction using an organozinc reagent
DE59304304D1 (de) Druckknopf zur arretierung von schnürsenkeln
DK0766745T3 (da) Monoklonalt antistof, som er specifikt for humant 4-1BB samt cellelinje, som producerer dette
CA2305618A1 (en) Process for the synthesis of 1,3-diols
AUPO903897A0 (en) Organic boronic acid derivatives
DK0534955T3 (da) Fremgangsmåde til fremstilling af en zeaxanthinholdig sammensætning under anvendelse af en mikroorganisme af arten Flavobacterium multivorum.
NZ515673A (en) Compositions and methods for labeling of nucleic acid molecules
EP1008600A3 (en) Compositions and methods for generating red chemiluminescence
ES2192919A1 (es) Catalizador a base de cobre tratado por reduccion y procedimiento para la produiccion de alcohol alfa-feniletilico utilizando el mismo.
AU1785099A (en) Novel gene having reverse transcriptase motif
ES2174444T3 (es) Procedimiento monoetapa para la obtencion de mono-eteres de glicol a partir de olefinas.
DE69809055T2 (de) Verfahren zur herstellung von reinem cis-tramadol
TR199801283T2 (xx) Yeni imalat prosesi.
HUP0003203A2 (hu) Eljárás bisz-indolil-maleimidek előállítására
ATE323703T1 (de) Synthese von verbindungen die zur herstellung von ketorolac dienen
ATE273258T1 (de) Verbesserung der enantioselektivität bei reduktionen mit boranreagenzien
AU2001247218A1 (en) Method and catalyst system for stereoselectively inverting chiral center of a chemical compound
ATE253030T1 (de) Verfahren zur herstellung von 1,1,4,4- tetramethoxybuten-2
DK1095157T3 (da) Fremgangsmåde til fremstilling af i vand uoplöselige alpha-1,4-glucaner
AU2001244217A1 (en) Process for preparing a 1,3-diol
BR0102643A (pt) Isomerização de pentol
NZ510205A (en) Process for the preparation of isoindoline involving catalytic hydrogenation of phthalonitrile
AU2002246065A1 (en) Methods and means for detecting enzymatic cleavage and linkage reactions
MY114407A (en) Process for the production of a flavouring agent
AU2001260144A1 (en) Process for preparing an alcohol from an olefin